54 results
8-K
EX-99.2
SAVA
Cassava Sciences Inc
12 Dec 23
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
9:19am
the strategic rationale for the warrant distribution. As you know, Cassava Sciences is a biotechnology company with an unwavering commitment
8-K
EX-99.1
SAVA
Cassava Sciences Inc
7 Nov 23
Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results
9:08am
, President & CEO. “This progress exemplifies our unwavering commitment to develop a new treatment option for people with Alzheimer’s.”
Simufilam is Cassava
8-K
EX-3.4
SAVA
Cassava Sciences Inc
13 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:17pm
written or oral) with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director … of the Company, will act or vote on any issue or question (a “Voting Commitment”) that has not been disclosed to the Company in such representation
8-K
EX-10.1
mx8yg5pgqev0a2me52c3
27 Oct 22
Cassava Sciences Announces Expansion of Leadership Team
4:03pm
8-K
EX-99.1
vzwlaq7wda1l4
14 Jun 21
Cassava Sciences Announces the Appointment of
4:14pm
8-K
EX-10.1
yekfpz l38p1p
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
424B5
qdhnvt5l2ujibvb
16 Nov 20
Prospectus supplement for primary offering
12:21pm
8-K
7rdrh9sssfa3ga
13 Nov 20
Cassava Sciences Announces Proposed Public Offering of Common Stock
4:36pm
424B5
gvvzy50co j8q
12 Nov 20
Prospectus supplement for primary offering
4:57pm